» Authors » Kristian Laake

Kristian Laake

Explore the profile of Kristian Laake including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 239
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Aune S, Helseth R, Kalstad A, Laake K, Akra S, Arnesen H, et al.
Diabetes Metab Syndr Obes . 2024 Jun; 17:2177-2190. PMID: 38827167
Background: Recent studies suggest gut-derived lipopolysaccharide (LPS)-translocation to play a role in both systemic inflammation and in inflammatory adipose tissue. We aimed to investigate whether circulating LPS-related inflammatory markers and...
2.
Myhre P, Berge T, Kalstad A, Tveit S, Laake K, Schmidt E, et al.
Clin Nutr . 2023 Jul; 42(9):1657-1660. PMID: 37515843
Background & Aims: Recent randomized clinical trials have raised concerns regarding potential off target adverse effects from supplementation of n-3 polyunsaturated fatty acids (PUFA) on atrial fibrillation (AF) risk. We...
3.
Nilsen D, Myhre P, Solheim S, Tveit S, Kalstad A, Laake K, et al.
Antioxidants (Basel) . 2023 Jun; 12(6). PMID: 37371887
Total bilirubin consists of an unconjugated form, solubilized by its binding to albumin, and a conjugated form representing a minor part of the circulating bilirubin. As total bilirubin in physiological...
4.
Berge T, Myhre P, Kalstad A, Laake K, Tveit S, Onarheim S, et al.
Cardiology . 2022 Dec; 148(1):72-77. PMID: 36538900
Background: Incident atrial fibrillation (AF) occurs in 5-10% of patients after acute myocardial infarction (AMI) and is associated with adverse outcomes. Guidelines now recommend screening for AF in all elderly...
5.
Myhre P, Kalstad A, Tveit S, Laake K, Schmidt E, Smith P, et al.
J Intern Med . 2022 Jan; 291(5):637-647. PMID: 34982486
Background: The cardiovascular benefit from n-3 polyunsaturated fatty acids (PUFAs) after acute myocardial infarction (AMI) is controversial, and the importance of serum eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) concentrations...
6.
Chiva-Blanch G, Bratseth V, Laake K, Arnesen H, Solheim S, Schmidt E, et al.
Clin Nutr . 2021 Nov; 40(12):5674-5677. PMID: 34742136
Background & Aims: Circulating microvesicles (cMV) are both effectors and biomarkers of cardiovascular disease (CVD), and the effects of omega 3 polyunsaturated fatty acids (n3 PUFA) in MV shedding are...
7.
Kalstad A, Myhre P, Laake K, Opstad T, Tveit A, Solheim S, et al.
Scand Cardiovasc J . 2021 Mar; 55(4):213-219. PMID: 33650449
. Ageing is one of the strongest risk factors for atrial fibrillation (AF), and additional risk factors are also closely related to ageing. Remodeling is part of the pathophysiology of...
8.
Kalstad A, Myhre P, Laake K, Tveit S, Schmidt E, Smith P, et al.
Circulation . 2020 Nov; 143(6):528-539. PMID: 33191772
Background: High intake of marine n-3 polyunsaturated fatty acids (PUFA) has been associated with reduced risk of cardiovascular events; however, this has not been confirmed in patients with a recent...
9.
Kalstad A, Tveit S, Myhre P, Laake K, Opstad T, Tveit A, et al.
BMC Geriatr . 2019 Dec; 19(1):376. PMID: 31881852
Background: Telomeres are non-coding sequences at the end of eukaryote chromosomes, which in complex with associated proteins serve to protect subtelomeric DNA. Telomeres shorten with each cell division, are regarded...
10.
Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, et al.
Nutrients . 2019 May; 11(5). PMID: 31109111
Circulating microvesicles (cMV) are small phospholipid-rich blebs shed from the membrane of activated vascular cells that contribute to vascular disease progression. We aimed to investigate whether the quality of the...